Merger to create largest global ovarian cancer research, legislative advocacy, and patient support organization
NEW YORK — Today, two of the nation’s foremost ovarian cancer research and advocacy organizations, the Ovarian Cancer National Alliance and Ovarian Cancer Research Fund announced a merger, forming the Ovarian Cancer Research Fund Alliance (OCRFA). This move comes at a critical time for ovarian cancer research, when scientific discoveries are rapidly increasing but federal funding is not keeping pace to support this progress. The newly formed OCRFA is the largest global organization dedicated to advancing ovarian cancer research and advocating for policies that give women access to the services they need before, during and after a diagnosis.
“The Ovarian Cancer Research Fund Alliance believes we can gain more ground together, fighting disease through a “one-stop shop” approach to research, advocacy, education and awareness,” said OCRFA President and CEO Audra Moran. “The formation of OCRFA will propel ovarian cancer prevention and treatment forward at an accelerated pace.”
Over the past 22 years, the Ovarian Cancer Research Fund and the Ovarian Cancer National Alliance have been leaders in the fight against ovarian cancer. Between the two organizations, nearly $70 million has been invested in research grants to diagnose, treat and cure ovarian cancer and advocacy efforts have helped to increase federal dollars for research and awareness to save the lives of women with this disease.
“This merger will unite the ovarian cancer community under one strong voice. OCRFA is committed to continuing and expanding the many patient-centered programs begun by both the Ovarian Cancer National Alliance and Ovarian Cancer Research Fund in the past, including, the Ovarian Cancer National Conference, Survivors Teaching Students and Woman to Woman®,” said OCRFA Executive Vice President Calaneet Balas. “Together, we are stronger, more efficient and more effective.”
For more information, visit www.ocrfa.org.
